CXCR4 and breast neoplasm: On one hand, it was found that the expression of CXCR7/ACKR3 by breast tumor cells has provided growth advantages to luminal breast tumor cells (at times even when CXCR4 was not active in this respect), and reduced trail-mediated apoptosis in such cells (56, 57).